Sahajanand Medical Technologies
SMT is a leading global developer and manufacturer of minimally invasive cardiovascular devices, committed to continuous innovation and improving patient care worldwide. With a presence in over 76 countries, SMT specializes in coronary, structural heart, and occluder devices, aiming to make life-saving healthcare technologies accessible and affordable for all. The company emphasizes quality, innovation, and social responsibility, with a mission to save millions of lives through advanced medical solutions.
Industries
Nr. of Employees
large (251-1000)
Sahajanand Medical Technologies
Sahajanand Estate, Wakhariawadi, Near Dabholi, Ved Road, Surat – 395 004, GJ, India.
Patents
Bioresorbable vascular implant having homogenously distributed stresses under a radial load
US-9566177-B2
View Details
Bioresorbable vascular implant having homogenously distributed stresses under a radial load
US-9566177-B2
View DetailsProducts
Drug-eluting coronary stent systems (ultrathin, biodegradable polymer-coated)
Ultrathin-strut metallic coronary stent systems with biodegradable polymer coatings for controlled elution of anti-proliferative drugs, intended for percutaneous coronary intervention with clinical evidence from randomized trials and registries.
Transcatheter aortic valve replacement (TAVR/TAVI) system
Self-expanding transcatheter aortic valve systems with integrated delivery catheters and features such as recapturable deployment, supra-annular bioprosthetic leaflets and marker-based implantation guidance; supported by clinical study data and regulatory clearances in multiple jurisdictions.
Occluder devices for septal and ductal defects
Transcatheter occlusion devices for percutaneous closure of atrial and ventricular septal defects and patent ductus arteriosus with nitinol-based implant components designed for biocompatibility and secure closure.
Balloon catheters including drug-coated PTA balloons
Range of compliant and non-compliant balloon catheters for angioplasty and stent delivery, including drug-coated balloons for peripheral indications and variable material constructions to tailor compliance.
Thrombus aspiration and mechanical aspiration systems
Catheters and aspiration systems engineered for mechanical removal of thrombus with features such as hydrophilic coatings, rapid-exchange designs and compatibility with standard guiding catheters; company also distributes third-party aspiration technologies.
Procedural accessories (inflation devices, connectors, torquers)
Ancillary interventional devices including inflation devices, hemostatic connectors and insertion/torquer tools with ergonomic designs, sealing technologies and defined pressure/compatibility specifications.
Drug-eluting coronary stent systems (ultrathin, biodegradable polymer-coated)
Ultrathin-strut metallic coronary stent systems with biodegradable polymer coatings for controlled elution of anti-proliferative drugs, intended for percutaneous coronary intervention with clinical evidence from randomized trials and registries.
Transcatheter aortic valve replacement (TAVR/TAVI) system
Self-expanding transcatheter aortic valve systems with integrated delivery catheters and features such as recapturable deployment, supra-annular bioprosthetic leaflets and marker-based implantation guidance; supported by clinical study data and regulatory clearances in multiple jurisdictions.
Occluder devices for septal and ductal defects
Transcatheter occlusion devices for percutaneous closure of atrial and ventricular septal defects and patent ductus arteriosus with nitinol-based implant components designed for biocompatibility and secure closure.
Balloon catheters including drug-coated PTA balloons
Range of compliant and non-compliant balloon catheters for angioplasty and stent delivery, including drug-coated balloons for peripheral indications and variable material constructions to tailor compliance.
Thrombus aspiration and mechanical aspiration systems
Catheters and aspiration systems engineered for mechanical removal of thrombus with features such as hydrophilic coatings, rapid-exchange designs and compatibility with standard guiding catheters; company also distributes third-party aspiration technologies.
Procedural accessories (inflation devices, connectors, torquers)
Ancillary interventional devices including inflation devices, hemostatic connectors and insertion/torquer tools with ergonomic designs, sealing technologies and defined pressure/compatibility specifications.
Services
Design and execution of randomized trials, prospective registries and imaging substudies with support for data analysis and peer-reviewed publication.
Large-scale manufacturing, quality-controlled production and direct supply of implantable devices and procedural accessories for coronary, peripheral and structural heart interventions.
Preparation of regulatory dossiers, facilitation of market approvals and support for reimbursement and tender submissions across multiple jurisdictions.
Commercial representation and exclusive distribution of third-party interventional technologies (e.g., mechanical and computer-aided aspiration systems) alongside in-house products.
Management of post-market registries, safety surveillance and long-term follow-up programs to support clinical evidence and regulatory obligations.
Design and execution of randomized trials, prospective registries and imaging substudies with support for data analysis and peer-reviewed publication.
Large-scale manufacturing, quality-controlled production and direct supply of implantable devices and procedural accessories for coronary, peripheral and structural heart interventions.
Preparation of regulatory dossiers, facilitation of market approvals and support for reimbursement and tender submissions across multiple jurisdictions.
Commercial representation and exclusive distribution of third-party interventional technologies (e.g., mechanical and computer-aided aspiration systems) alongside in-house products.
Management of post-market registries, safety surveillance and long-term follow-up programs to support clinical evidence and regulatory obligations.
Expertise Areas
- Interventional cardiovascular device R&D
- Clinical trial management and registry execution with peer-reviewed publication
- Transcatheter heart valve development and delivery systems
- Coronary and peripheral stent platform engineering
Key Technologies
- Biodegradable polymer drug-eluting coatings
- Ultrathin-strut metallic stent platforms
- Self-expanding, recapturable transcatheter heart valves
- Bioprosthetic pericardial leaflets with anti-calcification treatment
News & Updates
SMT introduces its Hydra TAVI system in Russia for advanced aortic stenosis care.
Expansion of SMT's global reach with the launch of Hydra TAVR system in Mexico.
The registry demonstrates outstanding performance of the Supraflex Cruz stent.
Regulatory approval for Hydra TAVI system in Singapore.
Results of the randomized controlled trial published in Circulation.
Regulatory approval for the Supraflex Cruz stent in Australia.
SMT introduces its Hydra TAVI system in Russia for advanced aortic stenosis care.
Expansion of SMT's global reach with the launch of Hydra TAVR system in Mexico.
The registry demonstrates outstanding performance of the Supraflex Cruz stent.
Regulatory approval for Hydra TAVI system in Singapore.
Results of the randomized controlled trial published in Circulation.
Regulatory approval for the Supraflex Cruz stent in Australia.